510(k) · Cleared
ClearedBD Veritor System for the Rapid Detection of RSV
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Becton, Dickinson & CO · GQG Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus
Cleared on Nov 15, 2013 as substantially equivalent to K120049 (Becton, Dickinson and Company, 2012) and 3 other predicates after a 29-day review. Its family tree reaches back 9 generations to 1990.
- Decided
- Nov 15, 2013
- Review
- 29 days
- Class
- Class I
- Product code
- GQG
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 9 generations to K902609 (1990). 14 ancestors in all. No later device cites it as a predicate yet.
- Root · 9 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
- 5 generations between
- 3 generations backK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
- 2 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 1 generation backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- This deviceK133140 BD Veritor System for the Rapid Detection of RSVBecton, Dickinson & CO · 2013
Show all 9 generations
- Root · 9 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
- 8 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
- 7 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
- 6 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
- 5 generations backK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
- 4 generations backK092698 Quickvue Influenza a+B TestQuidel Corp. · 2009
- 3 generations backK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
- 2 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- 1 generation backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
- This deviceK133140 BD Veritor System for the Rapid Detection of RSVBecton, Dickinson & CO · 2013
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −9 | K902609 | Directigen Flu a | Bd Becton Dickinson Vacutainer Systems Preanalytic | 1990 | — |
| −8 | K981651 | AB Flu Oia | Biostar, Inc. | 1998 | — |
| −7 | K023556 | Flu Oia a/B Test Kit | Thermo Biostar, Inc. | 2003 | 1 |
| −6 | K031899 | Quickvue Influenza a+B Test | Quidel Corp. | 2003 | — |
| −5 | K053146 | Quickvue Influenza a + B Test | Quidel Corp. | 2005 | — |
| −4 | K092698 | Quickvue Influenza a+B Test | Quidel Corp. | 2009 | — |
| −3 | K112277 | BD Veritor (TM) System for Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2011 | 1 |
| −2 | K132259 | BD Veritor System for the Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2013 | — |
| −1 | K132692 | BD Veritor System for the Rapid Detection of Flu a+B | Becton, Dickinson and Company | 2013 | — |
| 0 (this device) | K133140 | BD Veritor System for the Rapid Detection of RSV | Becton, Dickinson & CO | 2013 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2012 | 2 | 0 |
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GQG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GQG device
- #1 K253318 Clungene RSV Antigen Rapid Testscore 10.8 · 1 generation · no Class I recall
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K120049 | BD Veritor System for the Rapid Detection of Flu a+BSummary page 1…21 CFR 866.3330 PREDICATE DEVICES: BID VeritorTM System for Rapid Detection of Flu A+B POC (k120049, k121797, k132256, k132692) INTENDED USE: Clinical Kit The BD Veritor TM System for Rapid Detection of Flu A-IB is a rapid chr… | 2012 |
| * | K121797 | BD Veritor (TM) System for Rapid Detection of Flu a+BSummary page 1…21 CFR 866.3330 PREDICATE DEVICES: BID VeritorTM System for Rapid Detection of Flu A+B POC (k120049, k121797, k132256, k132692) INTENDED USE: Clinical Kit The BD Veritor TM System for Rapid Detection of Flu A-IB is a rapid chromatograp… | 2012 |
| * | K132256 | BD Veritor System for the Rapid Detection of Flu a+BSummary page 1…66.3330 PREDICATE DEVICES: BID VeritorTM System for Rapid Detection of Flu A+B POC (k120049, k121797, k132256, k132692) INTENDED USE: Clinical Kit The BD Veritor TM System for Rapid Detection of Flu A-IB is a rapid chromatographic immun… | 2013 |
| * | K132692 | BD Veritor System for the Rapid Detection of Flu a+BSummary page 1…PREDICATE DEVICES: BID VeritorTM System for Rapid Detection of Flu A+B POC (k120049, k121797, k132256, k132692) INTENDED USE: Clinical Kit The BD Veritor TM System for Rapid Detection of Flu A-IB is a rapid chromatographic immunoassay fo… | 2013 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 2.1 years on median.
- 2 of the 14 ancestors have a recall of any class.
- 5 other devices also cite its predicate K120049.
How does its category compare?
All GQG devicesGQG Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · GQG
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · GQG
93in 2013
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GQG
1in 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GQG
2in 2025
MAUDE reports naming product code GQG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 1 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 1 | — | 0 | 1 |
| 2010 | 2 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 3 | 93 | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 5 |
| 2022 | 0 | — | 0 | 3 |
| 2023 | 0 | — | 0 | 6 |
| 2024 | 1 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 2 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The IBD VoritorM System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a chromatographic immunoassay with an instrumented read for the direct and qualitative detection of RSV antigen from nasopharyngeal washes/aspirates and nasopharyngeal swabs in transport media from patients suspected of having a viral respiratory infection. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV Infections in neonatal and…
Read the full statement (147 words)
The IBD VoritorM System for Rapid Detection of Respiratory Syncytial Virus
(RSV) is a chromatographic immunoassay with an instrumented read for the
direct and qualitative detection of RSV antigen from nasopharyngeal
washes/aspirates and nasopharyngeal swabs in transport media from patients
suspected of having a viral respiratory infection. This test is intended for in vitro
diagnostic use to aid in the diagnosis of RSV Infections in neonatal and pediatric
patients under the age of 20. Negative results do not preclude RSV Infection and
should not be used as the sole basis for treatment or for other management
decisions. A negative test is presumptive. It is recommended that negative test
results be confirmed by viral cell culture or an alternative method, such as a
FDA-cleared molecular assay. The test is intended for professional and
laboratory use. It is to be used in conjunction with the BD VertorTM System
Reader.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K133140 · printed Nov 6, 2026
Cite this page
510(k) Report. “K133140: BD Veritor System for the Rapid Detection of RSV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K133140
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026